SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
52 hedge funds and large institutions have $438M invested in Sigilon Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
53% less capital invested
Capital invested by funds: $942M → $438M (-$503M)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.46M | |
| 2 | +$3.87M | |
| 3 | +$3.64M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.05M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.35M |
Top Sellers
| 1 | -$27M | |
| 2 | -$10.8M | |
| 3 | -$4.57M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.12M |